NASDAQ:UTHR

United Therapeutics Stock News

etoro logo Buy UTHR
*Your capital is at risk
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) COO Michael Benkowitz sold 22,500 shares of the stock in a transaction that occurred on Monday, February 9th. The shares were sold at a
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its fourth quarter and full year 2025 financial r
Candriam S.C.A. grew its position in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 48.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exc
Callan Family Office LLC reduced its holdings in United Therapeutics Corporation (NASDAQ: UTHR) by 49.0% during the undefined quarter, according to the company in its most recent Form 13F filing with
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) COO Michael Benkowitz sold 22,500 shares of the business's stock in a transaction on Monday, February 2nd. The stock was sold at an ave
Optimize Financial Inc acquired a new stake in shares of United Therapeutics Corporation (NASDAQ: UTHR) during the undefined quarter, according to its most recent filing with the SEC. The institutiona
Mediolanum International Funds Ltd cut its holdings in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 23.2% in the third quarter, according to the company in its most recent Form 13F fili
National Pension Service boosted its holdings in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 29.3% during the undefined quarter, according to the company in its most recent disclosure
Guru Stock PicksMurray Stahl has made the following transactions:Reduce in CVEO by 8.96%Add in SJT by 11.03%Eaton Vance Worldwide Health Sciences Fund has made
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) today announced positive results from its phase 1 study of miroliverELAP®, an extern
Exploring Baillie Gifford (Trades, Portfolio)'s Fourth Quarter 2025 Investment Adjustments Baillie Gifford (Trades, Portfolio) recently submitted the 13F filin
SILVER SPRING, Md. & DURHAM, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company's Board of Directors appointed Kevin
QRG Capital Management Inc. decreased its holdings in United Therapeutics Corporation (NASDAQ: UTHR) by 76.9% during the third quarter, according to its most recent filing with the Securities and Exch
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE